610017 SHPA Ann Rep 2003 Ruth - The Society of Hospital ...

More documents

Recommendations

Info

DIRECTORS REPORT Your directors present their report on the company for the financial year ended 30th June 2003. DIRECTORS The names of directors in office at any time during or since the end of the year are: Helen V Dowling Helen Matthews Sue W Kirsa Catherine I Drake Penelope D Thornton Naomi G Burgess Paul R Muir Neil J Keen Christine M Maclean Susan M Alexander Michael D Wiese Danielle A Stowasser Directors have been in office since the start of the financial year to the date of this report unless otherwise stated: Catherine I Drake was a director from 23 February 2003 until the date of this report. Michael D Wiese was a director from the beginning of the year until his resignation on 31 October 2002. PRINCIPAL ACTIVITIES The principal activities of the company during the financial year were: The provision of membership services, including bulletin, journal, publications, short courses and seminars, a clinical conference in New Zealand, a number of Branch conferences, development of practice standards and guidelines, providing accreditation for pharmacists seeking to provide domicilary medication reviews, promotion of the certified geriatric pharmacist credential, representation on government and related professional committees, special projects and preparation of discussion papers and submissions. No significant change in the nature of these activities occurred during the year. OPERATING RESULTS The profit of the company for the financial year after providing for income tax amounted to $283,142 DIVIDENDS No dividends were paid or declared since the start of the financial year. No recommendation for payment of dividends has been made. OPTIONS No options over issued shares or interests in the company were granted during or since end of the financial year and there were no options outstanding at the date of this report. REVIEW OF OPERATIONS A review of the operations of the company during the financial year and the results of those operations are as follows: Increased involvement and interaction with government, other professional organisations and collaboration with healthcare providers and consumers as guided by the Strategic Plan. Ongoing review of income, expenditure and revenue generation to improve financial performance. Working with Branches on services provided to members, whilst streamlining activities and processes. Development of member services by information on the website. Review and updating of the process for elevation to the status of Fellow of the Society. Completion of centralisation of Branch financial functions. Quarterly printing of the “Journal of Pharmacy Practice and Research”. FUTURE DEVELOPMENTS The likely developments in the operation of the company and the expected results of those operations in future financial years are the continuation of services with some use of reserves for specific projects to enhance professional practice. SIGNIFICANT CHANGES IN STATE OF AFFAIRS No significant changes in the company’s state of affairs occurred during the financial year. AFTER BALANCE DATE EVENTS No matters or circumstances have arisen since the end of the financial year which significantly affected or may significantly affect the operations of the company, the results of those operations or the state of affairs of the company in subsequent financial years. ENVIRONMENTAL ISSUES The company’s operations are not regulated by any significant environmental regulation under a law of the Commonwealth or of a State or Territory. 14 The Society of Hospital Pharmacists of Australia ABN 54 004 553 806 ANNUAL REPORT 2003
INFORMATION ON DIRECTORS Helen Matthews - President; BPharm; Chief Pharmacist, St Vincent’s Hospital, VIC Neil J Keen - Vice President; BPharm MPS; Senior Pharmacist-in-charge (Ward Services), Sir Charles Gairdner Hospital, WA Sue W Kirsa - Federal Treasurer; BPharm, Grad Dip Hosp Pharm; Senior Pharmacist, Austin Health, VIC Helen V Dowling - Immediate Past President; BPharm, Dip Hosp Pharm Admin; Grad Dip QI in Healthcare (CCEB); Director of Pharmacy, John Hunter Hospital, NSW Naomi G Burgess - Federal Councillor; BPharm, M Management (Health Services); Deputy Director of Pharmacy Services, Royal Adelaide Hospital, SA and Senior Lecturer, School of Pharmaceutical, Molecular and Biological Sciences, University of South Australia, SA. Penelope D Thornton - Federal Councillor; BPharm, FSHP; Deputy Director of Pharmacy, Westmead Hospital, NSW Paul R Muir - Federal Councillor; BPharm BA, FSHP; Senior Pharmacist, The Geelong Hospital, VIC Christine M Maclean - Federal Councillor; BPharm, FSHP; Assistant Director of Pharmacy, Princess Alexandra Hospital, QLD Susan M Alexander - Federal Councillor, BPharm, Director of Pharmacy, The Canberra Hospital, ACT Danielle A Stowasser - Federal Councillor; PhD, Dip Clin Hosp Pharm, BPharm, Program Area Manager, QIEP - Quality Use of Medicines, Queensland Health, QLD Catherine I Drake - Federal Councillor; BPharm (Hons), Grad Dip Pharm, Drug Utilisation & Evaluation Pharmacist, Royal Hobart Hospital, TAS Michael D Wiese - Former Federal Councillor; BPharm, Clinical Pharmacist Oncology, Royal Hobart Hospital, TAS During the financial year, 14 meetings of directors (including committees) were held. Attendances were:- Directors Meetings Divisional Meetings Number Eligible Number Number Eligible Number to Attend Attended to Attend Attended Naomi G Burgess 4 4 3 3 Helen V Dowling 5 5 0 0 Catherine I Drake 2 1 0 0 Neil J Keen 5 4 0 0 Sue W Kirsa 5 5 2 2 Christine M Maclean 4 3 2 2 Helen Matthews 5 5 0 0 Paul R Muir 4 4 2 2 Penny D Thornton 4 4 0 0 Susan M Alexander 5 4 0 0 Danielle A Stowasser 4 3 2 2 Michael D Wiese 1 1 0 0 INDEMNIFYING OFFICERS OR AUDITOR During or since the end of the financial year the company has given an indemnity or entered an agreement to indemnify, or paid or agreed to pay insurance premiums as follows: The company has paid premiums to insure each director against liabilities for costs and expenses incurred by them in defending any legal proceedings arising out of their conduct while acting in the capacity of director of the company, other than conduct involving a wilful breach of duty in relation to the company. The total premium for all directors was included in a policy that cost $ 6,282 inclusive of GST. PROCEEDINGS ON BEHALF OF COMPANY No person has applied for leave of Court to bring proceedings on behalf of the company or intervene in any proceedings to which the company is a party for the purpose of taking responsibility on behalf of the company for all or any part of those proceedings. The company was not a party to any such proceedings during the year. Signed in accordance with a resolution of the Board of Directors: Director ..................................... Helen Matthews Director ..................................... Sue W Kirsa Dated this 29th day of September 2003 ANNUAL REPORT 2003 ABN 54 004 553 806 The Society of Hospital Pharmacists of Australia 15
Page 1 and 2: The Society of Hospital Pharmacists
Page 3 and 4: Federal Council Members of Federal
Page 5 and 6: Advocacy Increasing the status, inf
Page 7 and 8: • Jeff Hughes, Andrew James, Mich
Page 9 and 10: Twenty-nine pharmacists, pre-regist
Page 11 and 12: QLD BRANCH.....QLD BRANCH.....QLD B
Page 13: From the Treasurer - Annual Financi
Page 17 and 18: STATEMENT OF CASH FLOWS FOR THE YEA
Page 19 and 20: NOTES TO THE FINANCIAL STATEMENTS F
Page 21 and 22: NOTES TO THE FINANCIAL STATEMENTS F
Page 23: Federal Operating Account FOR THE Y

610017 SHPA Ann Rep 2003 Ruth - The Society of Hospital ...

Create successful ePaper yourself

Delete template?

Save as template?